You are here

Article info

Article menu

Download PDFPDF

Response
A rebuttal to Akabayashi and colleagues’ criticisms of the iPSC stock project

Authors

  1. Correspondence to Dr Misao Fujita, Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8501, Japan; misao-fujita{at}cira.kyoto-u.ac.jp
View Full Text

Citation

Fujita M, Tabuchi K
A rebuttal to Akabayashi and colleagues’ criticisms of the iPSC stock project
Journal of Medical Ethics 2019;45:476-477.

Publication history

  • Received November 7, 2018
  • Revised December 19, 2018
  • Accepted December 21, 2018
  • First published January 11, 2019.
Online issue publication 
August 02, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Other content recommended for you